Evidence mapPaperPMID 42359768Full record

ArticlePhytochemical analysis : PCA2026

Integrating 3D Chromatography With Orbitrap Mass Spectrometry to Profile the Chemical Constituents in JTTZ Formula and Investigate Plasma Pharmacokinetic Changes in Obese Rats.

Linfeng Zhou, Nanqi Hou, Tong Hou, Zuoyang Li, Zepeng Zhang, Xiaolin Tong, Hang Su, Xiangyan Li

Abstract read
In one paragraph

Article in Phytochemical analysis : PCA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Linfeng ZhouChangchun University of Chinese Medicine, Changchun, China.
Nanqi HouChangchun University of Chinese Medicine, Changchun, China.
Tong HouChangchun University of Chinese Medicine, Changchun, China.
Zuoyang LiChangchun University of Chinese Medicine, Changchun, China.
Zepeng ZhangAffiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
Xiaolin TongChangchun University of Chinese Medicine, Changchun, China.
Hang SuChangchun University of Chinese Medicine, Changchun, China.
Xiangyan LiChangchun University of Chinese Medicine, Changchun, China.ORCID https://orcid.org/0000-0001-6780-6314

Funding

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine ZYYCXTD-D-202001National Natural Science Foundation of China 82405364Science and Technology Development Plan Project of Jilin Province 20230402040GH
6 · The paper itself

Abstract

introductionChemical profiling and exposure of multicomponent Chinese medicine formula (CMF) are essential for understanding the multitarget treatment mechanism, as they consist of bioactive substances with varying polarities, molecular weights, and charges. However, the chemical composition of CMF is highly intricate, primarily due to the presence of multiple herbs, rendering chemical identification a challenging task.

objectiveJiangtang Tiaozhi formula (JTTZ), commonly used for early diabetes intervention, was chosen to validate our standardized analytical strategy integrating offline three - dimensional (3D) chromatography-DDA (data-dependent acquisition) with a precursor ion list (PIL)-comparative pharmacokinetic study. MATERIALS AND

methodsWe have implemented an offline 3D chromatography coupled with data-dependent MS2 acquisition, including PIL, to obtain comprehensive compound information within JTTZ. We then utilized the MRM quantification approach to determine the pharmacokinetics of the 13 major circulating constituents identified in JTTZ. Finally, the variations in pharmacokinetic parameters between high-fat diet (HFD) and normal chow diet (NCD) rat models are further illustrated by comparative pharmacokinetics.

resultUsing an offline 3D chromatography platform, 186 compounds were identified in JTTZ, as opposed to the 68 compounds detected with classical one-dimensional (1D) LC-MS technology. Through the chemical profiling results of the multidimensional chromatography, we found 41 components of JTTZ absorbed in plasma. We then utilized the MRM quantification approach to determine the pharmacokinetics of the 13 major circulating constituents identified in JTTZ. Finally, the variations in pharmacokinetic parameters between HFD and normal chow diet (NCD) rat models are further illustrated by comparative pharmacokinetics. In the HFD group, the T

conclusionThe results show that the pathological state caused by a HFD changed the plasma pharmacokinetics of jatrorrhizine, mangiferin, and timosaponin BII in JTTZ, providing drug exposure evidence for the involvement of JTTZ in early diabetes intervention. The stepwise pipeline for the "offline 3D chromatography-DDA acquisition method with PIL-comparative pharmacokinetic study" in the case study of JTTZ has the potential to reveal the exposure profile of other CMFs, from compound identification to pharmacokinetic analysis.

Indexed as

Drugs, Chinese HerbalMass SpectrometryObesityAnimalsDiet, High-FatMaleRatsRats, Sprague-DawleyDrugs, Chinese Herbalcomparative pharmacokineticsfull MS/dd‐MS2 with PILhigh‐fat dietJTTZ (Jiangtang Tiaozhi formula)offline 3D chromatography

Identifiers

PMID42359768
PMCPMC13433733

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.